Fatima Jabri, Author at Zahrawi

November is Diabetes Awareness Month, a time when communities around the world bring attention to diabetes. Marking 100 years since the discovery of insulin, 2021 is a significant year in diabetes history.

For this special occasion, Bidaya team organized an event for Zahrawi Group employees to raise awareness about the high-stakes issues that are associated with diabetes. The event took place in Zahrawi Group Dubai offices, where all the employees were invited to be part of this initiative and attend the multiple educational presentations arranged by Dr. Huda Shoukfeh – General Practitioner at Dr. Mulham Polyclinic, Ms. Arwa Al Lahwani – Clinical Dietitian at Dr. Mulham Polyclinic and Dr. Bashar Jaradah – Dentist at Bella Vita Clinic.

Zahrawi Group employees also received free blood sugar and pressure tests, BMI tests, GP consultations, dental checkups, as well as many giveaways.

Bidaya team believes that raising awareness about Diabetes is critical, since it’s considered a “silent killer”, showing no to little symptoms in its initial stages.

Thank you to everyone who attended and thank you to Marah from Bidaya & Dana from FitForMe for all the efforts they put in to organize such a successful event.

For more information about obesity and related health issues, please check Bidaya website and don’t forget to follow their Instagram account for more tips and future events.

BIDAYA WEBSITE

BIDAYA INTAGRAM

Also, don’t forget to follow FitForMe UAE Instagram account for more tips about nutritional supplements, weight loss and bariatric surgery.

FITFORME UAE INSTAGRAM

Zahrawi Group Urology & Gastroenterology Unit had its first case of Optilume for urethral strictures end of October at Mediclinic Welcare hospital, Dubai. The surgery was performed by Dr. Salam Alhasani (Consultant Urologist) using Optilume an exciting and innovative minimally invasive urethral stricture treatment by our Partners Urotronic /Laborie.

The Optilume technology combines drug-coated balloon dilation, to expand or widen the strictured area, with delivering an anti-proliferative drug (paclitaxel) to reduce stricture recurrence and facilitate circumferential drug absorption. The Optilume was developed in response to severe patient and physician dissatisfaction with current stricture also this will end the high recurrence cycle of failed endoscopic stricture management

Congratulations to our Urology & Gastroenterology team, Dr. Salam Alhasani and the Urology team of Mediclinic for achieving such a great milestone.